Table 2. Baseline clinical data of 81 patients with advanced HCC.
| Presentation | Case (%) |
|---|---|
| Median age, yr (range) | 49 (28–67) |
| Gender, male (%) | 68 (83.95%) |
| Aetiology (%) | |
| HBV positive | 71 (87.65%) |
| HCV positive | 10 (12.35%) |
| ECOG PS (%) | |
| 0 | 31 (38.27%) |
| 1 | 46 (56.79%) |
| 2 | 4 (4.94%) |
| AFP (%) | |
| Normal | 17 (20.99%) |
| Elevated | 64 (79.01%) |
| extrahepatic metastasis (%) | 32 (39.50%) |
| LN metastasis (%) | 39 (48.14%) |
| Portal vein invasion (%) | 43 (53.08%) |
| Chilg-Pugh (%) | |
| A | 69 (85.18%) |
| B | 12 (14.82%) |
| Median size of index tumor, cm (range) | 1.4 (1–3.0) |
| Median number of index tumors | 2 (1–3) |
| Differentiation | |
| Well | 10 (12.34%) |
| Moderately | 44 (54.32%) |
| Poorly | 27 (33.33%) |
| Prior local therapy (%) | None |